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Abstract
Background:  Nasopharyngeal carcinoma (NPC) is a rare tumor in most parts of the world but
occurs at relatively high frequency among people of Chinese descent. The cytochrome P450 2E1
enzyme (CYP2E1) is responsible for the metabolic activation of nitrosamines, and has been shown
to be a susceptibility gene for NPC development in Taiwan [RR = 2.6; 95%CI = 1.2-5.7]. Since there
has been only one report of this link, it was decided to investigate the susceptibility of CYP2E1 to
N P C  d e v e l o p m e n t  i n  o t h e r  p o p u l a t i o n s .  T h e r e f o r e ,  t h e  c o r r e l a t i o n  b e t w e e n  t h e  RsaI
polymorphism of this gene and NPC was studied in-patients including Thai and Chinese in Thailand.
The present study comprised 217 cases diagnosed with NPC and 297 healthy controls.
Results:  Similar to the result found in Taiwanese, a homozygous uncut genotype demonstrated a
higher relative risk both when all cases were analyzed [RR = 2.19; 95%CI = 0.62-8.68] or individual
racial groups, Thai [RR = 1.51; 95%CI = 0.08-90.06] or Chinese [RR = 1.99; 95%CI = 0.39-10.87].
The ethnicity-adjusted odds ratio is 2.39 with 95%CI, 0.72-7.89.
Conclusions:  Though our finding was not statistically significant due to the moderate sample size
of the study, similarity to the study in Taiwan with only a slight loss in precision was demonstrated.
The higher RR found for the same genotype in distinct populations confirmed that CYP2E1 is one
of several NPC susceptibility genes and that the RsaI minus variant is one mutation that affects
phenotype.
Background
Nasopharyngeal carcinoma (NPC) is a rare tumor in
most parts of the world, with annual age-standardized
incidence rates typically below 1 per 100,000 people/
year in both sexes [1]. The tumor occurs most often in
Southern Chinese who reside in Guangdong Province, at
an incidence rate 30-50 per 100,000 people/year, in
contrast with <1 per 100,000 people/year in white Euro-
peans [2,3,4,5]. The disease also occurs at moderate fre-
quencies (3-10 per 100,000 people/year) in several non-
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Chinese ethnic groups such as Malay, Thai and Vietnam-
ese [6]. Numerous factors, both environmental and ge-
netic, have been associated with the risk of developing
NPC. The environmental factors include infection with
the Epstein-Barr virus (EBV), as well as frequent con-
sumption of high levels of nitrosamine from preserved
food such as salted fish [7,8,9]. In addition, host factors
also play a major role in NPC development. Unique alle-
les of the human leukocyte antigen (HLA) and cyto-
chrome P450 2E1 (CYP2E1) have been shown to be
associated with high relative risk in several Asian ethnic
groups, including the Chinese in Taiwan [10,11,12].
CYP2E1, an enzyme involved in the metabolic activation
of procarcinogens into reactive intermediates capable of
forming adducts and damaging DNA, is believed to play
an essential role in chemical carcinogenesis [13,14]. Nit-
rosamine is a substrate of CYP2E1. It is believed that ni-
trosamine, once activated can lead to the development of
numerous cancers [15]. Studies have also demonstrated
that CYP2E1 is expressed in the nasal epithelium of hu-
man [16]. Evidence from previous epidemiological stud-
ies has suggested that salted fish is a food preferred by
Chinese people and contains nitrosamines and nitro-
samine precursors [9]. Therefore, CYP2E1 is believed to
render the nasopharyngeal epithelium susceptible to
NPC development. A previous study in Taiwan employed
a PCR-RFLP (polymerase chain reaction-restriction
fragment length polymorphism) assay using the restric-
tion enzyme RsaI in order to compare wild-type (+/+)
and variant forms (-/-) of the CYP2E1 gene between NPC
patients and the general population [10,11]. The variant
form of contains CYP2E1 polymorphic mutations in the
distal 5'-flanking region of the gene, causing a marked
difference in its transcriptional activity, as shown by CAT
(chloramphenicol acetyltransferase) [17]. The Taiwanese
association study showed that individuals homozygous
for the variant allele (-/-) were at an increased risk for
NPC development (relative risk [RR] = 2.6; 95% confi-
dence interval [CI] = 1.2-5.7) [11]. There are many Chi-
nese people who have immigrated and permanently lived
in Thailand for 2 to 3 generations, resulting in a mixed
population of Thai and Chinese people. From clinical ob-
servation, we had observed at least one-third of NPC pa-
tients were Chinese in origin. Since the susceptibility of
CYP2E1 gene to develop NPC had only been reported
from Chinese people in Taiwan, it was decided to inves-
tigate whether this allele played the same role in other
populations. Therefore, we studied the correlation of the
polymorphism of the CYP2E1 gene with NPC in Thai and
Chinese populations in Thailand.
Materials and Methods
Sample collection
Blood samples were obtained by venipuncture from 217
NPC patients at Chulalongkorn Hospital and 297 healthy
blood donors. All subjects were interviewed and separat-
ed into two groups, Thai and Chinese, based on their
grandparents' ethnic origin. When their ancestors, in-
cluding their great grandparents, originated from China,
the patients were considered Chinese. When their ances-
tors originated from Thailand, the patients were consid-
ered Thai. There were 99 Thai and 98 Chinese in the
control group. The NPC patient group included 132 Thai
and 56 Chinese.
PCR-RFLP analysis
Genomic DNA (0.1 µ g) extracted from leukocytes was
used for each PCR analysis. The amplification was per-
formed with primers as described previously by Hayashi
et al. The total reaction volume of 50 µ l consisted of 20
µ M Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl2, 125
µ M deoxynucleoside triphosphate, 0.2 µ M primers, 4 U
Taq DNA polymorase (Gibco), and 0.2 µ g of template
DNA. The PCR conditions were 40 cycles at 92° C for 1
minute, 60° C for 1 minute and 72 for 2 minutes in a Per-
kin-Elmer/DNA thermal Cycle 480. Genotypes of
CYP2E1 gene were determined by RFLP analysis. Twenty
microliters of PCR products were digested with 10 U
RsaI restriction enzyme (New England Biolabs) over-
night at 37° C. The restricted products were analyzed by
electrophoresis on 2% agarose gel. Bands were visualized
with an ultraviolet transilluminator after ethidium bro-
mide staining.
Statistical Analysis
The relative risk (RR) was estimated by the odds ratio
method, to determine the correlation between genotype
of the CYP2E1 gene and NPC development. In addition,
the RR was used to estimate the association of the pat-
tern of genetic inheritance of the CYP2E1 gene and NPC
phenotype. The 95% confidence interval (CI) was com-
puted to determine the statistical significance of the find-
ings. The RR and 95%CI was calculated by using Exact
method from Epit info version6 program.
Results
In the present study, we investigated the correlation be-
tween the polymorphism of the CYP2E1 gene and NPC
on a total of 217 patients and 297 controls. The diagnosis
of NPC was confirmed histologically and by the presence
of EBV DNA in the tumor. PCR-RFLP analysis was used
to evaluate RsaI polymorphism in the CYP2E1 gene (fig
1). The distribution of alleles in all, Thai and Chinese
were found to be in Hardy-Weinberg equilibrium. The
calculated frequencies of heterozygous using 2x(+/+)1/2
x (-/-)1/2 were 0.32, 0.26, 0.42 from all, Thai, and Chi-BMC Cancer (2001) 1:4 http://www.biomedcentral.com/1471-2407/1/4
nese NPC patients, and 0.32, 0.26 and 0.42 from all,
Thai and Chinese control, respectively. These numbers
are similar to actual frequencies of heterozygous from all
groups, 0.32,0.28,0.42,0.35,0.28,0.52 from all, Thai and
Chinese patients and all, Thai and Chinese control, re-
spectively. We found the relative risk of the variant form
(-/-) of the CYP2E1 gene at a high risk [RR = 2.19]. How-
ever, this result had no statistical significance [95%CI =
0.62-8.68]. To evaluate whether the lack of significance
of the trend was due to a mixed genetic background, both
patients and controls were analyzed according to the or-
igins of their ancestors (Thai or Chinese). A slightly in-
creased risk of the variant from (-/-) of the CYP2E1 gene
could be demonstrated in both the Thai and Chinese
sample groups [RR = 1.51; 95%CI = 0.08-90.06, RR =
1.99; 95%CI = 0.39-10.87, respectively]. Nevertheless,
no statistical significance could be established. The esti-
mated crude odds ratio lies outside of two ethnicity-spe-
cific odds ratios for Thai and Chinese indicates ethnicity
is a confounder in this genotype-phenotype association.
Odds ratio for the combined group of subjects with eth-
nicity information can be calculated with adjustment for
ethnicity. The ethnicity-adjusted odds ratio (-/- vs +/-) is
1.86 (95%CI = 0.55-6.31). A similar adjustment using the
whole sample of three groups, Thai, Chinese, and ethnic-
ity unspecified showed an odd ratio of 2.39, with only a
slight loss in precision (95%CI = 0.72-7.89). This is clos-
er to the odds ratio of 2.6 from the study in Taiwan. Fur-
thermore, Thai-Taiwanese comparison was done
quantitatively by testing H0:OR(Thai)=OR(Taiwan). Us-
ing Mantel-Haenszel test for odds ratio homogeneity, the
p-value was 0.81. Thus there is no statistical different for
the role of CYP2E1 on NPC development between these
two populations.
In this study, we further analyzed the association of the
pattern of genetic inheritance of CYP2E1 gene and NPC
phenotype by calculating the relative risk if the genotype
were either autosomal dominant (AD) or autosomal re-
cessive (AR). In autosomal dominance, the contribution
of a single variant allele would show a higher RR. Thus
the RR for the combination of the heterozygous (+/-) and
the variant form (-/-) compared with wild type (+/+)
were computed. There was no association between AD
heredity and NPC risk in the total, Thai, and Chinese
sample groups [RR = 1.00; 95%CI = 0.68-1.47, RR =
1.01; 95%CI = 0.55-1.87, RR = 0.84; 95%CI = 0.41-1.71,
respectively] (Table 2). By contrast, AR inheritance re-
quires an abnormality in both alleles of the CYP2E1 gene.
The RR were calculated by comparison between the wild
type (+/+), the heterozygous (+/-) or the combination of
the wild type and heterozygous (+/+ and +/-) and the
variant form (-/-). A higher RR value in all comparisons
was shown for AR heredity in all sample groups (Table
Figure 1
PCR-RFLP assay to detect the polymorphism of the CYP2E1 gene by RsaI enzyme digesting the 410 bp PCR product into 360 bp
and 50 bp fragments. Lane 1, homozygous variant (-/-); Lane 2, heterozygous (+/-); Lane 3, homozygous wild type (+/+).BMC Cancer (2001) 1:4 http://www.biomedcentral.com/1471-2407/1/4
3). However, these results showed no statistical signifi-
cance for either the AD or AR pattern.
Discussion
We have shown an increased risk of developing NPC as-
sociated with the homozygous variant form of the
CYP2E1 gene. This higher RR was demonstrated in both
the Thai and Chinese populations in Thailand. This find-
ing was similar to the result reported from Taiwan. How-
ever, these results were marginal statistical significance,
which may well be due to the small sample size employed
in the present study. Thus the CYP2E1 gene appears to be
a susceptibility gene for NPC development regardless of
the patient's genetic background. Patients of both Thai
and Chinese ethnic origin revealed a higher relative risk
from the same allele, despite their distinct ancestry. Thus
it is more likely that the RsaI negative allele affects the
phenotype directly rather than being a consequence of
linkage disequilibrium from another mutation or gene.
This confirms the previous finding that the polymorphic
RsaI site was essential for a marked difference in tran-
scriptional activities [17]. A higher level of expression in
the variant form would result in larger amounts of pro-
carcinogens being changed into carcinogens, that then
produce DNA damage. The affect of the distinct expres-
sion level of a metabolic gene should be reduced if the
Table 1: Frequency distribution and relative risks associated with 
genotype variants ofCYP2E1 detected RFLP using RsaI
CYP2E1 Frequency RR 95%CI
Cases Controls
Total 217* 297
+ / + 138 189 1.00
+ / - 71 103 0.94 0.64 - 1.39
- / - 8 52.19 0.62 - 8.68
Thai 132 99
+ / + 93 70 1.00
+ / - 37 28 0.99 0.54 - 1.86
- / - 2 1 1.51 0.08 - 90.06
Chinese 56 98
+ / + 27 43 1.00
+ / - 24 51 0.75 0.36 - 1.57
- / - 54 1.99 0.39 - 10.87
* 29 cases lack precise information regrarding ethnicity +, The allele 
could be digested with RsaI enzyme -, The allele could not be digested 
with RsaI enzyme
Table 2: Correlation between Autosomal Dominant (AD) pat-
tern of geneticCYP2E1 gene and NPC phenotype
CYP2E1 Frequency RR (AD) 95%CI
Cases Controls
Total
+ / + 138 189 1.00
+ / - and - / - 79 108 1.00 0.68 - 1.47
Thai
+ / + 93 70 1.00
+ / - and - / - 39 29 1.01 0.55 - 1.87
Chinese
+ / + 27 43 1.00
+ / - and - / - 29 55 0.84 0.41 - 1.71
+, The allele could be digested with RsaI enzyme -, The allele could not 
be digested with RsaI enzyme
Table 3: Correlation between Autosomal Recessive (AR) pattern 
of geneticCYP2E1 gene and NPC phenotype
CYP2E1 Frequency RR (AR) 95%CI
Cases Controls
Total
+ / + 138 189 1.00
- / - 8 52.19 0.62 - 8.68
+ / - 71 103 1.00
- / - 8 52.32 0.64 - 9.36
+ / + and + / - 209 292 1.00
- / - 8 52.24 0.63 - 8.80
Thai
+ / + 93 70 1.00
- / - 2 1 1.51 0.08 - 90.06
+ / - 37 28 1.00
- / - 2 1 1.51 0.07 - 92.44
+ / + and + / - 130 98 1.00
- / - 2 1 1.51 0.08 - 89.84
Chinese
+ / + 27 43 1.00
- / - 54 1.99 0.39 - 10.87
+ / - 24 51 1.00
- / - 54 2.66 0.5 1 - 14.48
+ / + and + / - 51 94 1.00
- / - 54 2.30 0.47 - 12.08
+, The allele could be digested with RsaI enzyme -, The allele could not 
be digested with RsaI enzymeBMC Cancer (2001) 1:4 http://www.biomedcentral.com/1471-2407/1/4
person with abnormal genotype is not exposed to the
substrate. For example, Phenylketonuria (PKU) patients
would not demonstrate mental retardation if they were
prevented completely from exposure to tyrosine [18]. In
other words, a mutation can not cause the phenotype
without interaction from environmental factors. Regard-
ing NPC development, the role of CYP2E1 variant may be
varied upon the amount of consumed salted fish and/or
preserved foods that contain nitrosamine and nitro-
samine precursors.
Conclusion
Result of the reported crude odds ratio is 2.19 [95%CI =
0.62-8.68]. If the result is adjusted odds ratio, it will be
2.39 [95%CI = 0.72-7.89], which is closer to the Taiwan-
ese odds ratio of 2.6, with only a slight loss in precision.
Thus, this study confirmed a previous study in Taiwan
that CYP2E1 appears to be one of a number of NPC sus-
ceptibility genes and the RsaI minus variant is not just a
polymorphism but directly influences the development
of the phenotype.
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